Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

[Gastric aspiration therapy is a possible alternative to treatment of obesity

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Epidemiologi for alkoholrelateret leversygdom

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Skadelige konsekvenser af alkoholindtag blandt unge mennesker

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Rygning kan have skadelige effekter selv ved ophør før 30-årsalderen

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Behandling af indlæggelseskrævende COVID-19

    Research output: Contribution to journalReviewpeer-review

  5. Udredning og opfølgning af indlæggelseskrævende COVID-19

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Aspiration therapy with AspireAssist is a novel endoscopic obesity treatment. Patients aspirate approximately 30% of an ingested meal through a draining system connected to a percutanous endoscopic gastrostomy tube. AspireAssist was recently approved by the US Food and Drug Administration, and it induces weight loss comparable to the weight loss observed after bariatric surgery, but with a lower risk of complications. Few clinical studies about the efficacy and safety of AspireAssist have been carried out and published. Thus, further intervention studies evaluating acute as well as long-term effects are warranted.

Original languageEnglish
JournalUgeskrift for Laeger
Volume179
Issue number32
ISSN0041-5782
Publication statusPublished - 7 Aug 2017

    Research areas

  • English Abstract, Journal Article

ID: 52650250